Over the past decade, few supplements have generated as much interest in the healthy ageing and longevity space as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). Both are promoted as ways to increase levels of NAD, a molecule essential for cellular energy production, DNA repair and many of the biochemical processes required for normal cellular function.
The interest is understandable. NAD levels appear to decline with age, and a growing body of research suggests this decline may contribute to some of the physiological changes associated with ageing. The idea that restoring NAD levels could support healthier ageing has therefore attracted significant attention from researchers, clinicians and supplement companies alike.
At the same time, enthusiasm has often moved ahead of the evidence. While some aspects of NAD biology are now well established, other claims remain speculative. As a result, many people are left wondering what NMN and NR actually do, whether one is better than the other and whether they are fundamentally different from more traditional forms of vitamin B3.
What Is NAD?
NAD, short for nicotinamide adenine dinucleotide, is found in every living cell and is essential for life. It plays a central role in converting food into usable energy and also serves as a cofactor for enzymes involved in DNA repair, cellular signalling and the regulation of gene expression.
Although NAD is extensively recycled through salvage pathways, it is also continually consumed and broken down during normal cellular processes. As a result, the body must constantly replenish its NAD pool. Research in both animals and humans suggests that NAD levels may decline with age in at least some tissues. This observation has led researchers to explore whether increasing NAD availability could support aspects of cellular function that become less efficient over time.
While this is a biologically plausible hypothesis, it is important to recognise that human physiology is complex and that restoring a single biomarker does not automatically translate into improved health, slower ageing or better clinical outcomes.
Why Not Just Take NAD?
A logical question is why researchers became interested in NMN and NR in the first place. If declining NAD is the problem, why not simply take NAD itself?
While oral NAD supplements are now widely available, the science surrounding their absorption and metabolism remains less clear than it is for NMN and NR. NAD may be broken down into smaller components before absorption and subsequently recycled by the body. Although oral NAD appears capable of influencing NAD metabolism, the evidence supporting NMN and NR as reliable NAD-raising compounds is currently more robust. For this reason, most research has focused on providing the body with NAD precursors rather than NAD itself.
What Are NMN And NR?
NMN and NR are naturally occurring compounds that act as precursors to NAD. They are not forms of NAD themselves, but rather compounds the body can convert into NAD through established metabolic pathways.
NMN and NR enter the NAD production pathway later than niacin and niacinamide, meaning fewer conversion steps are required before they can contribute to NAD synthesis. This has led researchers to investigate whether they may provide a more efficient way of increasing NAD levels compared with some other vitamin B3 compounds.
At this point, a reasonable question arises: if niacin and niacinamide can also contribute to NAD production, why all the excitement about NMN and NR?
The answer is that we do not yet know whether all NAD precursors behave identically once inside the body. NR and NMN may influence NAD metabolism differently because of where they enter the pathway, and some researchers believe this could potentially translate into differences in biological effects. At present, however, this remains one of the key unanswered questions in the field.
Do We Absorb Them?
One of the early criticisms of NMN supplementation was the suggestion that it might not be absorbed intact from the gastrointestinal tract. Research over the past several years has largely moved beyond this debate. Human studies consistently demonstrate that oral NMN supplementation increases NAD levels, indicating that the compound, either directly or following metabolic conversion, ultimately contributes to NAD production.
The evidence for NR is similarly reassuring. Human trials have repeatedly shown that oral NR supplementation raises NAD concentrations in blood and tissues.
The practical takeaway is that both compounds appear capable of increasing NAD levels in humans. The current discussion is less about whether they work and more about whether one performs meaningfully better than the other.
Is NMN Better Than NR?
At present, there is no clear evidence that either compound is universally superior.
Both NMN and NR reliably increase NAD levels in human studies. Some research suggests differences in the magnitude of NAD increases under certain conditions, but comparisons are complicated by variations in dose, study design, participant characteristics and outcome measures.
Marketing material often presents the choice as though one compound has clearly emerged as the winner. The current evidence does not support that conclusion. A more accurate summary is that both appear effective at increasing NAD, while the question of whether one delivers superior clinical outcomes remains unresolved.
Do Higher NAD Levels Mean Longer Life?
There is now reasonably strong evidence that NMN and NR increase NAD levels in humans. What remains unclear is whether this ultimately translates into longer lifespan, reduced disease risk or meaningful improvements in healthy ageing.
Animal studies have produced encouraging findings in areas such as metabolic health, mitochondrial function and vascular health. Human studies, however, remain relatively small and short-term, and there is currently no convincing evidence that either NMN or NR extends human lifespan.
That does not mean the concept is wrong. It simply means the most important outcomes are still being investigated.
Are They Safe?
The safety data available so far are generally reassuring. Human trials involving both NMN and NR have reported good tolerability across a range of doses, with relatively few significant adverse effects identified.
However, it is worth recognising that these compounds have not been studied over the course of decades in the way many medications have. While there are currently no major safety signals, long-term outcome data remain limited.
As is often the case in nutrition science, “appears safe based on current evidence” and “proven safe under all circumstances” are not quite the same thing.
Do You Need To Take TMG?
One of the most common questions surrounding NAD precursors concerns methylation support and the use of trimethylglycine (TMG).
The concern arises because NAD metabolism ultimately produces nicotinamide, which is cleared through pathways that utilise methyl groups. Some researchers and clinicians have therefore suggested that long-term use of NMN or NR could increase demand for methyl donors.
There is a reasonable biochemical rationale behind this idea, which is one reason many professional formulations include nutrients such as TMG, folate, vitamin B12, choline or combinations thereof. A number of researchers and clinicians working in the longevity field also recommend supporting methylation when higher doses of NAD precursors are used.
At the same time, the evidence is not yet strong enough to conclude that everyone taking NMN or NR will inevitably develop a methylation problem or requires supplemental TMG. At present, the question remains incompletely settled, which helps explain why recommendations vary between practitioners, researchers and supplement formulations.
The Bottom Line
NMN and NR are legitimate NAD precursors that reliably increase NAD levels in humans. Both appear to be absorbed, both appear capable of raising NAD and both have demonstrated generally reassuring short-term safety profiles.
What remains uncertain is whether increasing NAD levels ultimately translates into meaningful improvements in longevity, disease prevention or healthy ageing. The biological rationale is compelling, the early research is encouraging and the field continues to evolve rapidly. However, many of the claims currently made about these compounds extend well beyond what has been demonstrated in humans.
For now, the most defensible position is probably one of cautious interest. NAD biology remains one of the more promising areas of ageing research, but many of the most important questions have yet to be answered.
Article written by
Peter Christinson
Certified Practicing Nutritionist
Vive Health – Retail and Clinic Manager
